---
schema_version: "secwatch.filing_event.v1"
accession: "0001528287-24-000004"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2024-03-05T23:59:59+00:00"
generated_at: "2026-06-05T03:45:47.539086+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NeuroPace reports record 2023 revenue $65.4M (+44% YoY); guides 2024 revenue $73M-$77M

## Summary
- Record FY 2023 revenue $65.4M (+44% YoY); Q4 revenue $18.0M (+41% YoY). Net loss improved to $33.0M from $47.1M.
- Gross margin improved to 73.6% (FY) from 71.4%; Q4 75.2% vs 68.8%. Cash burn reduced to $3.4M in Q4.
- FY 2024 guidance: revenue $73M-$77M (+12-18%), gross margin 72-74%, operating expenses $80M-$84M.
- NAUTILUS study for generalized epilepsy completed enrollment and implants for FDA submission; Project CARE pilot initiated.
- Cash position $66.5M, long-term debt $57.0M; stock-based comp ~$9.6M in 2023.

## SEC filing metadata
- accession: 0001528287-24-000004
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2024-03-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000152828724000004/0001528287-24-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000152828724000004/npce-20240305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001528287-24-000004
- JSON: https://secwatch.observer/filing/0001528287-24-000004.json
- Plain text: https://secwatch.observer/filing/0001528287-24-000004.txt

## Key facts
- Earnings Releases
  NeuroPace Inc reported fourth quarter and full year ended December 31, 2023 results: revenue $18.0 million, net income $6.2 million. Guidance initiated.
  - Period: fourth quarter and full year ended December 31, 2023
  - Revenue: $18.0 million
  - Net income: $6.2 million
  - Guidance: initiated
  - Result: reported results
  source text: NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million Revenue increased to $18.0 million in Q4 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000152828724000004/0001528287-24-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.